Back
Biomarin Pharmaceutical Stock Predictions
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More
Sell
32
BMRN
Biomarin Pharmaceutical
Last Price:
70.07
Seasonality Move:
6.37%
7 Day Trial
ALL ACCESS PASS
$
7
Supercharge Your Portfolio with This High-Traction AI Startup
Learn MoreBiomarin Pharmaceutical Stock Forecast
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 11.2% based on the past 25 years of stock performance.
- Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Biomarin Pharmaceutical Stock Undervalued?
The current Biomarin Pharmaceutical [BMRN] share price is $70.10. The Score for BMRN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal. - BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Biomarin Pharmaceutical Stock Go Up Next Year?
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 11.2% based on the past 25 years of stock performance.
Biomarin Pharmaceutical Stock Rating
Sell
32
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical overpriced?
- Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Biomarin Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
99.56
52-Week Low:
67.75
Prediction Charts
Market Cap:
13.35B
Price in USD:
70.10
Volume:
1.01M
Beta:
0.88
Technical Analysis
SMA50:
83.37
SMA100:
82.34
SMA200:
85.93
52-Wk Change:
-20.77%
Stock Predictions
-
Is Biomarin Pharmaceutical stock public?
Yes, Biomarin Pharmaceutical is a publicly traded company. -
What is the Biomarin Pharmaceutical stock quote today?
The Biomarin Pharmaceutical stock price is 70.10 USD today. -
How to buy Biomarin Pharmaceutical stock online?
You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Sep-12 | 84.83 | 84.35 | 85.00 | 83.91 |
| Sep-13 | 84.43 | 84.90 | 85.00 | 83.95 |
| Sep-16 | 77.53 | 69.86 | 78.00 | 69.60 |
| Sep-17 | 70.00 | 70.55 | 71.64 | 68.83 |
| Sep-18 | 70.87 | 71.14 | 71.58 | 70.11 |
| Sep-19 | 71.75 | 71.43 | 72.07 | 70.42 |
| Sep-20 | 71.82 | 70.69 | 71.82 | 70.09 |
| Sep-23 | 70.30 | 69.13 | 70.92 | 69.00 |
| Sep-24 | 69.13 | 69.48 | 69.65 | 67.75 |
| Sep-25 | 69.03 | 69.02 | 69.54 | 68.12 |
| Sep-26 | 69.21 | 70.22 | 70.33 | 68.70 |
| Sep-27 | 70.55 | 70.58 | 71.00 | 70.24 |
| Sep-30 | 70.58 | 70.28 | 71.24 | 69.91 |
| Oct-1 | 70.66 | 70.10 | 70.74 | 69.81 |
Biomarin Pharmaceutical Earnings
Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biomarin Pharmaceutical Forecast Revenue Growth
Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.